MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
33 hedge funds and large institutions have $172M invested in Mirati Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+7
Holders Change %
+26.92%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
11
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.4M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$4.58M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$4.54M |
| 4 |
AG
Artal Group
Luxembourg
|
+$1.43M |
| 5 |
Morgan Stanley
New York
|
+$873K |
Top Sellers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$9.59M |
| 2 |
First Eagle Investment Management
New York
|
-$4.53M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$1.13M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$832K |
| 5 |
BC
Broadfin Capital
New York
|
-$563K |
